Clinical Trial
Specific active immunochemotherapy in lung cancer: a survival study
- PMID: 301428
Item in Clipboard
Clinical Trial
Specific active immunochemotherapy in lung cancer: a survival study
Can J Surg.
1977 Jul.
Abstract
A radomized clinical trial of chemotherapy, immunization and immunochemotherapy among 55 patients with stages I and II carcinoma of the lung is reported. The survival rate in the immunized groups was significantly better (P = 0.001) than that in the nonimmunized groups. The results are discussed in the light of the reactivity of the patients to the specific cancer antigen.
Similar articles
-
Immunochemotherapy of lung cancer.Ann N Y Acad Sci. 1976;277(00):436-66. doi: 10.1111/j.1749-6632.1976.tb41720.x. Ann N Y Acad Sci. 1976. PMID: 1087137 Clinical Trial.
-
Specific active immunochemotherapy in lung cancer: a survival study.Recent Results Cancer Res. 1978;68:278-85. doi: 10.1007/978-3-642-81332-0_43. Recent Results Cancer Res. 1978. PMID: 752865 No abstract available.
-
[Transfer factor immunochemotherapy for primary lung cancer--evaluation of histologic types].Gan No Rinsho. 1983 Oct;29(12):1409-16. Gan No Rinsho. 1983. PMID: 6315989 Japanese.
-
[Surgery and adjuvant therapy of non-small cell lung cancer].Gan To Kagaku Ryoho. 1986 Apr;13(4 Pt 2):1534-46. Gan To Kagaku Ryoho. 1986. PMID: 3524465 Review. Japanese.
-
Active specific immunotherapy and immunochemotherapy in the treatment of lung and colon cancer.Semin Surg Oncol. 1991 Jul-Aug;7(4):199-210. doi: 10.1002/ssu.2980070405. Semin Surg Oncol. 1991. PMID: 1925251 Review.
Cited by
-
Lung cancer: an overview.Can Fam Physician. 1979 Oct;25:1185-7. Can Fam Physician. 1979. PMID: 21297791 Free PMC article.
-
Immunotherapy for remission maintenance in acute myeloblastic leukemia.Cancer Immunol Immunother. 1982;13(2):85-8. doi: 10.1007/BF00205305. Cancer Immunol Immunother. 1982. PMID: 6760961 Free PMC article. Clinical Trial.